Adoptive T cell therapies, in which a patient’s own immune cells are genetically engineered to target their cancer cells, ...

Media reports about supermodel Macpherson’s cancer journey omitted crucial information about the type of breast cancer she ...

The new injectable formulation of Tecentriq reduces treatment time to seven minutes compared with up to an hour for IV ...

American Cancer Society survey finds misconceptions about prostate cancer screening; awareness campaign launched with Alonzo Mourning.

However, study results suggest higher doses may benefit patients with tumors on the left side of the colon or rectum.

Keytruda doubled disease-free survival for people with muscle-invasive bladder cancer after surgery. Results from a large ...

An interview with Anusha Kalbasi, MD, a radiation oncologist who studies CAR-T therapy to treat advanced melanoma, a type of ...

Researchers report good 10-year survival for people with melanoma and improvements for those with breast and bladder cancer.

Antibody-drug conjugate trastuzumab deruxtecan was found effective against brain metastases in patients with HER2-positive ...

Young patients can safely breastfeed without increasing the risk of cancer recurrence or new cancer in the opposite breast.

Zynyz immunotherapy added to chemotherapy extended progression-free survival and may improve overall survival.

The decision marks the first time the agency has approved a treatment called a T-cell receptor (TCR) therapy for cancer.